TPNBT has been included in the “Portfolio Technology” program of Genome Spain

Technical Proteins Nanobiotechnology (TPNBT – a spinoff of university of Valladolid promoted by BIOFORGE’s members, and the Genome Spain Foundation signed last March a framework agreement which will fund the preclinical validation process of an injectable bioactive implant for the regeneration of articular tissues that has been successfully tested in animals. Its preclinical validation trials will start with the financing of the public foundation Genome Spain. More information is available at the follow links.